Halozyme Therapeutics Inc (NASDAQ:HALO)

18.60
Delayed Data
As of May 18
 +0.31 / +1.69%
Today’s Change
11.41
Today|||52-Week Range
21.48
-8.19%
Year-to-Date

Today’s Trading

Previous close18.29
Today’s open18.38
Day’s range18.20 - 18.62
Volume911,811
Average volume (3 months)1,037,393
Market cap$2.9B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-290.40%
Earnings growth (next 5 years)+22.89%
Revenue growth (last year)+115.84%
P/E ratio35.8
Price/Sales8.90
Price/Book13.62

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.34-1.07%
BPMCBlueprint Medicines ...+0.17+0.21%
XLRNAcceleron Pharma Inc+1.04+3.00%
XONIntrexon Corp-0.16-1.00%
Data as of 4:02pm ET, 05/18/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$316.6M
Annual profit (last year)$63.0M
Net profit margin19.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts